BB
Virtus Biotech Clinical Trials ETF (BBC)
NYSE_ARCA·Financial Services·Asset Management
$43.12
+2.13%
Mkt Cap $38.35M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$210.45
Range $142.74 – $247.05
Implied Upside
+388.1%
Consensus $210.45 vs current $43.12